Dr. Kapil Mehta
Distinguished Senior Lecturer
The University of Texas MD Anderson Cancer Center
Department of Experimental Therapeutics
Development of resistance to a wide range of chemotherapeutic drugs and metastasis pose major impediment in successful treatment of cancer. Our laboratory is investigating intrinsic pathways/proteins that are deregulated in cancer cells and contribute to the development of these phenotypes. Another area of research in our lab is targeted delivery of drugs, using liposomes as delivery system.
Office: MDA 4SCR3.1006 (Unit 1950)
Ph.D. - Postgraduate Institute-Medical Education/Research - 1981